Latest & greatest articles for breast cancer screening

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on breast cancer screening or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on breast cancer screening and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for breast cancer screening

121. Effect of screening mammography on breast-cancer mortality in Norway. Full Text available with Trip Pro

Effect of screening mammography on breast-cancer mortality in Norway. A challenge in quantifying the effect of screening mammography on breast-cancer mortality is to provide valid comparison groups. The use of historical control subjects does not take into account chronologic trends associated with advances in breast-cancer awareness and treatment.The Norwegian breast-cancer screening program was started in 1996 and expanded geographically during the subsequent 9 years. Women between the ages (...) of 50 and 69 years were offered screening mammography every 2 years. We compared the incidence-based rates of death from breast cancer in four groups: two groups of women who from 1996 through 2005 were living in counties with screening (screening group) or without screening (nonscreening group); and two historical-comparison groups that from 1986 through 1995 mirrored the current groups.We analyzed data from 40,075 women with breast cancer. The rate of death was reduced by 7.2 deaths per 100,000

2010 NEJM

122. Revisiting the USPSTF Breast Cancer Screening Guidelines: Ethics, and Patient Responsibilities

Revisiting the USPSTF Breast Cancer Screening Guidelines: Ethics, and Patient Responsibilities Revisiting the USPSTF Breast Cancer Screening Guidelines: Ethics, and Patient Responsibilities – Clinical Correlations Search Revisiting the USPSTF Breast Cancer Screening Guidelines: Ethics, and Patient Responsibilities May 6, 2010 5 min read | | 4 comments on “ Revisiting the USPSTF Breast Cancer Screening Guidelines: Ethics, and Patient Responsibilities ” Comments are closed. Sites We Follow

2010 Clinical Correlations

123. Breast cancer mortality in organised mammography screening in Denmark: comparative study. Full Text available with Trip Pro

Breast cancer mortality in organised mammography screening in Denmark: comparative study. To determine whether the previously observed 25% reduction in breast cancer mortality in Copenhagen following the introduction of mammography screening was indeed due to screening, by using an additional screening region and five years additional follow-up.We used Poisson regression analyses adjusted for changes in age distribution to compare the annual percentage change in breast cancer mortality in areas (...) Denmark for 1971-2006.Annual percentage change in breast cancer mortality in regions offering mammography screening and those not offering screening.In women who could benefit from screening (ages 55-74 years), we found a mortality decline of 1% per year in the screening areas (relative risk (RR) 0.99, 95% confidence interval (CI) 0.96 to 1.01) during the 10 year period when screening could have had an effect (1997-2006). In women of the same age in the non-screening areas, there was a decline of 2

2010 BMJ

124. A rapid-response economic evaluation of the UK NHS Cancer Reform Strategy breast cancer screening program extension via a plausible bounds approach

A rapid-response economic evaluation of the UK NHS Cancer Reform Strategy breast cancer screening program extension via a plausible bounds approach Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2010 NHS Economic Evaluation Database.

125. Interventions to promote repeat breast cancer screening with mammography: a systematic review and meta-analysis

Interventions to promote repeat breast cancer screening with mammography: a systematic review and meta-analysis Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2010 DARE.

126. Breast tomosynthesis: a breast cancer screening tool

Breast tomosynthesis: a breast cancer screening tool Horizon Scanning Technology Prioritising Summary Breast tomosynthesis: a breast cancer screening tool Update: November 2009 © Commonwealth of Australia 2009 ISBN Publications Approval Number: This work is copyright. You may download, display, print and reproduce this material in unaltered form only (retaining this notice) for your personal, non-commercial use or use within your organisation. Apart from any use as permitted under the Copyright (...) of Population Health and Clinical Practice, Mail Drop DX 650 545, University of Adelaide, Adelaide, SA, 5005. Breast tomosynthesis: November 2009 Update 1 PRIORITISING SUMMARY (UPDATE 2009) REGISTER ID: 000373 NAME OF TECHNOLOGY: BREAST TOMOSYNTHESIS PURPOSE AND TARGET GROUP: BREAST CANCER SCREENING TOOL 2009 COMPARATORS No new comparators were identified during the preparation of this update. 2009 SAFETY AND EFFECTIVENESS ISSUES A study by (Teertstra et al 2009) investigated digital mammography

2009 Australia and New Zealand Horizon Scanning Network

127. Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement. (Abstract)

Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement. Update of the 2002 U.S. Preventive Services Task Force (USPSTF) recommendation statement on screening for breast cancer in the general population.The USPSTF examined the evidence on the efficacy of 5 screening modalities in reducing mortality from breast cancer: film mammography, clinical breast examination, breast self-examination, digital mammography, and magnetic resonance imaging in order to update (...) and harms of either digital mammography or magnetic resonance imaging instead of film mammography as screening modalities for breast cancer. (I statement).

2009 Annals of Internal Medicine

128. Screening for Breast Cancer: An Update for the U.S. Preventive Services Task Force. Full Text available with Trip Pro

Screening for Breast Cancer: An Update for the U.S. Preventive Services Task Force. This systematic review is an update of evidence since the 2002 U.S. Preventive Services Task Force recommendation on breast cancer screening.To determine the effectiveness of mammography screening in decreasing breast cancer mortality among average-risk women aged 40 to 49 years and 70 years or older, the effectiveness of clinical breast examination and breast self-examination, and the harms (...) of screening.Cochrane Central Register of Controlled Trials and Cochrane Database of Systematic Reviews (through the fourth quarter of 2008), MEDLINE (January 2001 to December 2008), reference lists, and Web of Science searches for published studies and Breast Cancer Surveillance Consortium for screening mammography data.Randomized, controlled trials with breast cancer mortality outcomes for screening effectiveness, and studies of various designs and multiple data sources for harms.Relevant data were abstracted

2009 Annals of Internal Medicine

129. Rethinking screening for breast cancer and prostate cancer. Full Text available with Trip Pro

be increasing the burden of low-risk cancers without significantly reducing the burden of more aggressively growing cancers and therefore not resulting in the anticipated reduction in cancer mortality. To reduce morbidity and mortality from prostate cancer and breast cancer, new approaches for screening, early detection, and prevention for both diseases should be considered. (...) Rethinking screening for breast cancer and prostate cancer. After 20 years of screening for breast and prostate cancer, several observations can be made. First, the incidence of these cancers increased after the introduction of screening but has never returned to prescreening levels. Second, the increase in the relative fraction of early stage cancers has increased. Third, the incidence of regional cancers has not decreased at a commensurate rate. One possible explanation is that screening may

2009 JAMA

130. Computer-aided detection mammography for breast cancer screening: systematic review and meta-analysis

Computer-aided detection mammography for breast cancer screening: systematic review and meta-analysis Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2009 DARE.

131. Magnetic resonance imaging screening of the contralateral breast in women with newly diagnosed breast cancer: systematic review and meta-analysis of incremental cancer detection and impact on surgical management

Magnetic resonance imaging screening of the contralateral breast in women with newly diagnosed breast cancer: systematic review and meta-analysis of incremental cancer detection and impact on surgical management Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2009 DARE.

132. [Diagnostic performance of digital mammography in breast cancer screening]

[Diagnostic performance of digital mammography in breast cancer screening] Rendimiento diagnostico de la mamografia digital en el cribado del cancer de mama [Diagnostic performance of digital mammography in breast cancer screening] Rendimiento diagnostico de la mamografia digital en el cribado del cancer de mama [Diagnostic performance of digital mammography in breast cancer screening] Marquez Cruz MD, Marquez Calderon S Record Status This is a bibliographic record of a published health (...) technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Marquez Cruz MD, Marquez Calderon S. Rendimiento diagnostico de la mamografia digital en el cribado del cancer de mama. [Diagnostic performance of digital mammography in breast cancer screening] Seville: Andalusian Agency for Health Technology Assessment (AETSA). Informes de Evaluacion de Tecnologias Sanitarias AETSA 2007/09. 2009 Authors' conclusions No important

2009 Health Technology Assessment (HTA) Database.

133. Screening for breast cancer: systematic evidence review update for the U.S. Preventive Services Task Force Full Text available with Trip Pro

been shown for CBE or BSE. Project page URL Final publication URL Indexing Status Subject indexing assigned by NLM MeSH Adult; Age Factors; Aged; Anxiety /etiology; Breast Neoplasms /diagnosis /mortality; Breast Self-Examination; Early Detection of Cancer; Female Costss; Magnetic Resonance Imaging /economics; Mammography /adverse effects /economics /methods; Mass Screening /economics /methods; Middle Aged; Palpation /economics; Risk Factors Language Published English Country of organisation United (...) Screening for breast cancer: systematic evidence review update for the U.S. Preventive Services Task Force Screening for breast cancer: systematic evidence review update for the U.S. Preventive Services Task Force Screening for breast cancer: systematic evidence review update for the U.S. Preventive Services Task Force Nelson HD, Tyne K, Naik A, Bougatsos C, Chan B, Nygren P, Humphrey L Record Status This is a bibliographic record of a published health technology assessment from a member

2009 Health Technology Assessment (HTA) Database.

134. Review: adequately randomised trials showed that mammography screening did not significantly reduce breast cancer, cancer, or all cause mortality but increased breast surgeries

Review: adequately randomised trials showed that mammography screening did not significantly reduce breast cancer, cancer, or all cause mortality but increased breast surgeries Review: adequately randomised trials showed that mammography screening did not significantly reduce breast cancer, cancer, or all cause mortality but increased breast surgeries | Evidence-Based Nursing We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie (...) showed that mammography screening did not significantly reduce breast cancer, cancer, or all cause mortality but increased breast surgeries Article Text Treatment Review: adequately randomised trials showed that mammography screening did not significantly reduce breast cancer, cancer, or all cause mortality but increased breast surgeries Statistics from Altmetric.com Request Permissions If you wish to reuse any or all of this article please use the link below which will take you to the Copyright

2008 Evidence-Based Nursing

135. Annual mammographic screening beginning at 40 years of age did not significantly reduce breast cancer mortality after 10 years in women

Annual mammographic screening beginning at 40 years of age did not significantly reduce breast cancer mortality after 10 years in women Annual mammographic screening beginning at 40 years of age did not significantly reduce breast cancer mortality after 10 years in women | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies (...) , please see our . Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Annual mammographic screening beginning at 40 years of age did not significantly reduce breast cancer mortality after

2008 Evidence-Based Medicine

136. (1) ACS guidelines for breast cancer screening: update 2003. (2) American Cancer Society Guideline for breast screening with MRI as an adjunct to mammography (2007).

(1) ACS guidelines for breast cancer screening: update 2003. (2) American Cancer Society Guideline for breast screening with MRI as an adjunct to mammography (2007). Guidelines and Measures | Agency for Healthcare Research & Quality HHS.gov Search ahrq.gov Search ahrq.gov Menu Topics A - Z Healthcare Delivery Latest available findings on quality of and access to health care Searchable database of AHRQ Grants, Working Papers & HHS Recovery Act Projects AHRQ Projects funded by the Patient

2008 American Cancer Society

137. Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer. Full Text available with Trip Pro

Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer. Screening ultrasound may depict small, node-negative breast cancers not seen on mammography.To compare the diagnostic yield, defined as the proportion of women with positive screen test results and positive reference standard, and performance of screening with ultrasound plus mammography vs mammography alone in women at elevated risk of breast cancer.From April 2004 to February (...) (assessed by the area under the receiver operating characteristic curve) of combined mammography plus ultrasound vs mammography alone and the positive predictive value of biopsy recommendations for mammography plus ultrasound vs mammography alone.Forty participants (41 breasts) were diagnosed with cancer: 8 suspicious on both ultrasound and mammography, 12 on ultrasound alone, 12 on mammography alone, and 8 participants (9 breasts) on neither. The diagnostic yield for mammography was 7.6 per 1000 women

2008 JAMA Controlled trial quality: predicted high

138. Breast Tomosynthesis: a breast cancer screening tool

Breast Tomosynthesis: a breast cancer screening tool Breast Tomosynthesis: a breast cancer screening tool Breast Tomosynthesis: a breast cancer screening tool Mundy L, Hiller JE Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Mundy L, Hiller JE. Breast Tomosynthesis: a breast cancer screening tool. Adelaide: Adelaide Health Technology (...) Assessment (AHTA). Prioritising Summary. Volume 21. 2008 Final publication URL Indexing Status Subject indexing assigned by CRD MeSH Breast Neoplasmss; Imaging, Three-Dimensional; Mammography Language Published English Country of organisation Australia English summary An English language summary is available. Address for correspondence Adelaide Health Technology Assessment, University of Adelaide, Discipline of Public Health, School of Population Health and Clinical Practice, Mail Drop DX650545, SA 5005

2008 Health Technology Assessment (HTA) Database.

139. Systematic review: using magnetic resonance imaging to screen women at high risk for breast cancer.

recurrence and survival. Funding Ontario Ministry of Health and Long-Term Care through Cancer Care Ontario Bibliographic details Warner E, Messersmith H, Causer P, Eisen A, Shumak R, Plewes D. Systematic review: using magnetic resonance imaging to screen women at high risk for breast cancer. Annals of Internal Medicine 2008; 148(9): 671-679 PubMedID Indexing Status Subject indexing assigned by NLM MeSH Breast Neoplasms /diagnosis /genetics; Female; Genetic Predisposition to Disease; Humans; Likelihood (...) Systematic review: using magnetic resonance imaging to screen women at high risk for breast cancer. Systematic review: using magnetic resonance imaging to screen women at high risk for breast cancer. Systematic review: using magnetic resonance imaging to screen women at high risk for breast cancer. Warner E, Messersmith H, Causer P, Eisen A, Shumak R, Plewes D CRD summary This review evaluated the diagnostic accuracy of adding magnetic resonance imaging (MRI) to annual mammographic screening

2008 DARE.

140. Cost-effectiveness of digital mammography breast cancer screening

Cost-effectiveness of digital mammography breast cancer screening Cost-effectiveness of digital mammography breast cancer screening Cost-effectiveness of digital mammography breast cancer screening Tosteson A N, Stout N K, Fryback D G, Acharyya S, Herman B A, Hannah L G, Pisano E D Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed (...) by a detailed critical assessment on the reliability of the study and the conclusions drawn. CRD summary This study aimed to determine the cost-effectiveness of digital mammography screening, compared with film mammography screening, for the detection of breast cancer (BC) in women aged 40 years or more than 65 years. The study showed that screening for BC using all-digital mammography is not cost-effective, while age-targeted screening with digital mammography has the potential to be cost-effective

2008 NHS Economic Evaluation Database.